ABSTRACT:
This study examined the effect of Eurycoma longifolia (ELO) extract on the pharmacokinetic profile of rosiglitazone in diabetic male rats. Old diabetics male rats were divided into intravenous and oral administration groups. Each group was further divided into two sub-groups for a single rosiglitazone and a combination of ELO extract and rosiglitazone (n = 6). Oral administration of the ELO extract at a dose of 50 mg/kg BW, 30 min before rosiglitazone administration, was performed for intravenous and oral studies. Blood samples (0.5 mL) were collected from the test animals at 0 (predose), 0.25, 0.5, 1, 2, 3, 5, 8, and 12 h after intravenous injection and at 24h for oral studies. The HPLC method reported by Mamidi et al. (2003) was used to analyse the rosiglitazone levels. A T-test was employed to compare pharmacokinetic parameters. The AUC0--8, Kel, and T1/2 decreased by 31.49%, 3.03%, and 3.85%, respectively, after intravenous injection. By contrast, the Vd and CL increased by 37.63% and 15.50%, respectively. Whereas for oral study shows a decrease in some pharmacokinetic parameters, namely AUC0--8 (8.01%), Cmax (12.95%), T1/2 (7.23%), and F (5.71%), and an increase in the parameters Kel (13.04%), Tmax (15.52%), Vd (46.38%), and CL (43.30%). Intravenous study results revealed that ELO had no effect on the rosiglitazone pharmacokinetic profile (P>0.05). Meanwhile for the oral study, ELO did not significantly decrease rosiglitazone bioavailability but significantly increased the CL and Vd parameters (P < 0.05).
Cite this article:
Purwantiningsih, Agung E. Nugroho. Interaction Study: Effect of Eurycoma longifolia (ELO) extract on Rosiglitazone Pharmacokinetic profile in Diabetic rats. Research Journal of Pharmacy and Technology. 2025;18(5):2356-2. doi: 10.52711/0974-360X.2025.00337
Cite(Electronic):
Purwantiningsih, Agung E. Nugroho. Interaction Study: Effect of Eurycoma longifolia (ELO) extract on Rosiglitazone Pharmacokinetic profile in Diabetic rats. Research Journal of Pharmacy and Technology. 2025;18(5):2356-2. doi: 10.52711/0974-360X.2025.00337 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-5-60
REFERENCES:
1. Zhang K. Yan G. Zhang A. Sun H. Wang X. Recent advances in pharmacokinetics approach for herbal medicine. RSC Advances. 2017; 7: 28876-88. doi:10.1039/C7RA02369C
2. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. National Health Statistics Reports. 2008: 12: 1-24. https://www.cdc.gov/nchs/data/nhsr/nhsr012.pdf
3. Bussmann RW, Sharon D. Markets, healers, vendors, collectors: the sustainability of medicinal plant use in northern Peru. Mountain Research and Development. 2009; 29(2): 28–34. doi:10.1659/mrd.1083
4. Van-Andel T, Carvalheiro LG. Why urban citizens in developing countries use traditional medicines: The case of Suriname. Evidence-Based Complementary and Alternative Medicines. 2013; Article ID:687-197:1-13. http://dx.doi.org/10.1155/2013/687197
5. Brazier NC, Levine MAH. Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals. American Journal of Therapeutics. 2003; 10: 163-9. doi:10.1097/00045391-200305000-00003
6. Zhou S, Chan E, Pan SQ, Huang M, Lee EJ. Pharmacokinetic interactions of drugs with St John's wort. Journal of Psychopharmacology. 2004; 18: 262-76. doi:10.1177/0269881104042632
7. Newall CA, Anderson LA, Phillipson JD. Herbal medicines. A guide for health-care professionals. 1st ed. London: The Pharmaceutical Press; 1996.
8. Ernst E. The Risk-Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John’s Wort, Ginseng, Echinecea, Saw Palmetto, and Kava. Annals of Internal Medicine. 2002;136: 42-53. doi:10.7326/0003-4819-136-1-200201010-00010
9. Mills E, Cooper C, Seely D, Kanfer I. African Herbal Medicines in the Treatment of HIV: Hypoxis and Sutherlandia. An overview of evidence and pharmacology. Nutrition Journal. 2005; 4: 19. doi:10.1186/1475-2891-4-19
10. Low BS, Das PK, Chan KL. Standardized quassinoid-rich Eurycoma longifolia extract improved spermatogenesis and fertility in male rats via the hypothalamic–pituitary–gonadalaxis. Journal of Ethnopharmacology. 2013; 145: 706–14. doi:10.1016/j.jep.2012.11.013
11. Fugh-Berman A. Herb-drug interactions. Lancet. 2000; 355: 134-38. doi:10.1016/j.jep.2012.11.013
12. Saxena A, Tripathi KP, Roy S, Khan F, Sharma A. Pharmacovigilance: Effects of herbal components on human drugs interactions involving Cytochrome P450. Bioinformation. 2008; 3(5): 198-204. doi:10.6026/97320630003198
13. Salman SAB, Amrah S, Wahab MSA, Ismail Z, Ismail R, Yuen KH, Gan SH. Modification of propranolol’s bioavailability by Eurycoma longifolia water-based extract. Journal of Clinical Pharmacy and Therapeutics. 2010; 35(6): 691-6. doi:10.1111/j.1365-2710.2009.01147.x
14. Purwantiningsih, Hussin AH, Chan KL. Phase I drug metabolism study of the standardised extract of Eurycoma longifolia (TAF-273) in rat hepatocytes. International Journal of Pharmacy and Pharmaceutical Sciences. 2010; 2(3): 147-52. https://www.innovareacademics.in/journal/ijpps/Vol2Suppl3/684.pdf
15. Purwantiningsih, Hussin AH, Chan KL. Sex-Related Alterations of Aminopyrine Metabolism by Standardized Extract of Eurycoma longifolia (TAF-273). Acta Alimentaria. 2012;41(3):316-26. doi:10.1556/AAlim.41.2012.3.3
16. Purwantiningsih, Hussin, AH, Chan, KL. Herb-Drug Interaction Study of Eurycoma longifolia Extract (TAF-273) on Antidiabetic Drug (Rosiglitazone) Metabolism, Asian Journal of Pharmaceutical and Clinical Research. 2011; 4(2): 88-92. https://www.innovareacademics.in/journal/ajpcr/Vol4Issue2/292.pdf
17. Low BS, Ng BH, Choy WP, Yuen KH, Chan KL. Bioavailability and pharmacokinetic studies of eurycomanone from Eurycoma longifolia. Planta Medica. 2005; 71: 803-807. doi:10.1055/s-2005-871259
18. Muzeeb S, Venkatesh P, Mullangi R, Srinivas NR. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats. Xenobiotic. 2006; 36(9): 838-856. doi:10.1080/00498250600839369
19. Mamidi RNVS, Benjamin B, Ramesh M, Srinivas NR. Simple method for the determination of rosiglitazone in human plasma using a commercially available internal standard. Biomedical Chromatography. 2003; 17(6): 417-420. doi:10.1002/bmc.272
20. Johnston A, Woollard RC. STRIPE: an interactive computer program for the analysis of drug pharmacokinetics. Journal of Pharmacological Methods. 1983; 9(3): 193-199. doi:10.1016/0160-5402(83)90038-4
21. Shargel L, Wu-Pong S, Yu ABC. Applied biopharmaceutics and pharmacokinetics (5th ed.). New York: The McGraw Hill Companies Inc; 2005.
22. Jaynthi B, Parameshwar P, Baba TMD, Patil KP, Cheranjeevi G. Effect of insulin sensitizer, rosiglitazone in streptozotocine induced diabetic db/db mice model. Research Journal of Pharmacy and Technology. 2012; 5(5): 619-23.
23. Nwauche, Kelechi TG, Monago CC, Anacletus FC. Management of Diabetic Induced Hyperlipidemia with Combined Therapy of Reducdyn and Metformin in Streptozotocin Induced Diabetic Male Rats. Research Journal of Pharmacy and Technology. 2014; 7(8): 910-14.
24. Rajput P, Firke S. Analytical Techniques for Estimation of Rosiglitazone. Asian Journal of Pharmaceutical Analysis. 2019; 9(3): 167-76.
25. Ramolia C, Dedania Z, Dedania R, Sheth NR, Sagar GV, Patel B, Bhatt KK. Simultaneous Estimation of Metformin Hydrochloride, Rosiglitazone Maleate and Glimepiride in Pharmaceutical Dosage Forms by RP-HPLC Method. Asian Journal of Research in Chemistry. 2010; 3(1): 83-86.
26. Jiladia MA, Pandya SS, Jiladia AG, Viidyasagar G. Estimation of Rosiglitazone in Bulk and Tablet Dosage Forms by HPTLC Method. Asian Journal of Research in Chemistry. 2010; 3(1): 26-28.
27. Godge RK, Lateef SN, Giri MA, Chaudhari PD, Merekar AN, Kendre PN. Oral Sustained Delivery of Rosiglitazone Maleate Floating Matrix Tablets- Formulation and In Vitro Evaluation. Research Journal of Pharmaceutical Dosage Forms and Technology. 2009; 1(3): 257-62.
28. Parthiban C, Raju BM, Sudhakar M. A Novel Simultaneous Estimation of Metformin, Glimepiride and Rosiglitazone in Tablet Dosage Form by RP-HPLC Method. Research Journal of Pharmacy and Technology. 2011; 4(10): 1576-80.
29. Theja GD, Debnath S, Bora R, Jeyaprakash MR. Impurity Summarizing on Rosiglitazone by RP-HPLC Analytical Method. Research Journal of Pharmacy and Technology. 2019; 12(11): 5529-35.
30. Izzo AA, Borrelli F, Capasso R. Herbal medicine: the dangers of drug interaction. Trends in Pharmacological Sciences. 2002; 23: 358-359. doi:10.1016/s0165-6147(02)02059-x
31. Izzo AA. Drug interactions with St. John’s wort (Hypericum perforatum): a review of the clinical evidence. International Journal of Clinical Pharmacology and Therapeutics. 2004; 42: 139-48. doi:10.5414/cpp42139
32. Manzi SF, Shannon M. Drug Interactions-A Review. Clinical Paediatric Emergency Medicine. 2005; 6: 93-102. doi:10.1016/j.cpem.2005.04.006
33. Ioannides C. Xenobiotic Metabolis: an Overview. In: C. Ioannides Editor, Enzymes Systems The Metabolise Drugs and Other Xenobiotics. West Sussex: John Wiley & Sons, Ltd. 2002, p. 1-30.
34. Zhou SF, Gao YH, Wen QJ, Huang M, Xu AL, Paxton JW. Interactions of herbs with cytochrome P450. Drug Metabolism Reviews. 2003;35:35-98. doi:10.1081/dmr-120018248
35. Rosenbaum SE. Basic Pharmacokinetics and Pharmacodynamics. An Integrated Textbook and Computer Simulations. Hoboken, New Jersey, Canada: John Wiley & Sons, Inc; 2011.
36. Barre J, Urien S. Distribution of drugs. In Sirtori CR, Kuhlmann J, Tillement JP, Vrhovac B. Editors, Clinical Pharmacology. London: McGraw-Hill International Lt. 2000, p.37-43.
37. Correia MA. Drug Biotransformation. In Katzung GB Editor, Basic and Clinical Pharmacology (8th ed). New York: Lange Medical Books/Mc Graw Hill Medical Publishing Division. 2001, p. 51-63.
38. Taufiqurrachman, Wibowo S. Effect of Eurycoma longifolia Jack root extract (Eurycoma longifolia) in elevation of testosterone levels, LH and FSH in Sprague Dawley male rats. Media Medica Indonesia 2000; 35(2): 81-86.
39. Baldwin SJ, Clarke SE, Chenery RJ. Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone. British Journal of Clinical Pharmacology. 1999; 48 :424-432. doi:10.1046/j.1365-2125.1999.00030.x
40. Cox PJ, Ryan DA, Hollis FJ, Harris AM, Miller AK, Vousden M, Cowley H. Absorption, disposition, and metabolism of rosiglitazone, a potent thiazolidinedione insulin sensitizer, in humans. Drug Metabolism and Disposition. 2000; 28(7): 772-80. https://dmd.aspetjournals.org/content/28/7/772.long
41. Fugh-Berman A, Ernst E. Herb-drug interactions: review and assessment of report reliability. British Journal of Clinical Pharmacology. 2001; 52: 587-95. doi:10.1046/j.0306-5251.2001.01469.x
42. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs. 2001; 61: 2163-75. doi:10.2165/00003495-200161150-00002
43. Mahata PP, Thakur A, Chakraborty S, Bala NN. A Review on Pharmacist’s Role in Mitigation of Food-Drug Interactions. Research Journal of Pharmacy and Technology. 2015; 8(4): 423-31.
44. Rastogi H, Sharma G, Sharma A, Jana S. In-Vitro Assessment of the Inhibitory effects of Dietary flavones on the regulated metabolism of CYP 450: Potential for Herb-drug interactions. Research Journal of Pharmacy and Technology. 2020; 13(12): 6086-92.